Evidence map›Paper›PMID 26913198›Full record

ArticleGigaScience2016

Galaxy-M: a Galaxy workflow for processing and analyzing direct infusion and liquid chromatography mass spectrometry-based metabolomics data.

Robert L Davidson, Ralf J M Weber, Haoyu Liu, Archana Sharma-Oates, Mark R Viant

Abstract read
In one paragraph

Article in GigaScience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. "What I wish I had known before starting my PhD".Analytical science advances · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert L DavidsonGigaScience, BGI-Hong Kong Co. Ltd, Tai Po Industrial Estate, 16 Dai Fu Street, Tai Po, NT Hong Kong ; School of Biosciences, University of Birmingham, Birmingham, B15 2TT UK.
Ralf J M WeberSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT UK.
Haoyu LiuSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT UK.
Archana Sharma-OatesSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT UK.
Mark R ViantSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT UK.

Funding

Biotechnology and Biological Sciences Research Council BB/M019985/1
6 · The paper itself

Abstract

backgroundMetabolomics is increasingly recognized as an invaluable tool in the biological, medical and environmental sciences yet lags behind the methodological maturity of other omics fields. To achieve its full potential, including the integration of multiple omics modalities, the accessibility, standardization and reproducibility of computational metabolomics tools must be improved significantly.

resultsHere we present our end-to-end mass spectrometry metabolomics workflow in the widely used platform, Galaxy. Named Galaxy-M, our workflow has been developed for both direct infusion mass spectrometry (DIMS) and liquid chromatography mass spectrometry (LC-MS) metabolomics. The range of tools presented spans from processing of raw data, e.g. peak picking and alignment, through data cleansing, e.g. missing value imputation, to preparation for statistical analysis, e.g. normalization and scaling, and principal components analysis (PCA) with associated statistical evaluation. We demonstrate the ease of using these Galaxy workflows via the analysis of DIMS and LC-MS datasets, and provide PCA scores and associated statistics to help other users to ensure that they can accurately repeat the processing and analysis of these two datasets. Galaxy and data are all provided pre-installed in a virtual machine (VM) that can be downloaded from the GigaDB repository. Additionally, source code, executables and installation instructions are available from GitHub.

conclusionsThe Galaxy platform has enabled us to produce an easily accessible and reproducible computational metabolomics workflow. More tools could be added by the community to expand its functionality. We recommend that Galaxy-M workflow files are included within the supplementary information of publications, enabling metabolomics studies to achieve greater reproducibility.

Indexed as

SoftwareChromatography, LiquidComputational BiologyMass SpectrometryMetabolomeMetabolomicsPrincipal Component AnalysisReproducibility of ResultsWorkflowFourier transform ion cyclotron resonanceFT-ICRGalaxy projectLC-MSLipidomicsLiquid chromatography mass spectrometryMetabolomicsPipelineReproducibilityWorkflow

Identifiers

PMID26913198
PMCPMC4765054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.